Isomorphic Labs announces a $600 million investment to enhance its AI drug design engine, leveraging advanced AI research and development. This funding aims to advance therapeutic programs globally, focusing on innovative methodologies that could reshape the pharmaceutical landscape, potentially impacting drug discovery processes in various countries.
💊 Isomorphic Labs Secures $600M for Next-Gen AI Drug Design
